Hemoadsorption in the critically ill - Final results of the International CytoSorb Registry
Izdano u: | PLoS One 17(2022)10, S. e0274315 |
---|---|
Glavni autori: | Hawchar, Fatime (Autor), Tomescu, Dana (Autor), Henzler, Dietrich (Autor) |
Format: | Članak |
Jezik: | English |
Izdano: |
2022
|
Teme: | |
Online pristup: | https://doi.org/10.1371/journal.pone.0274315 |
Povezana djela: | In:
PLoS One |
Similar Items
-
Does adjunctive hemoadsorption with CytoSorb affect survival of COVID-19 patients on ECMO? A critical statement
od: Köhler, Thomas, i dr.
Izdano: (2021) -
Hemoadsorption with CytoSorb and the early course of linezolid plasma concentration during septic shock
od: Köhler, Thomas, i dr.
Izdano: (2022) -
Therapeutic Modulation of the Host Defense by Hemoadsorption with CytoSorb-Basics, Indications and Perspectives-A Scoping Review
od: Köhler, Thomas, i dr.
Izdano: (2021) -
High-dose CytoSorb hemoadsorption is associated with improved survival in patients with septic shock : a retrospective cohort study
od: Schultz, Philipp, i dr.
Izdano: (2021) -
Quality of life and outcome of patients with metastatic pancreatic cancer receiving first-line chemotherapy with nab-paclitaxel and gemcitabine: Real-life results from the prospective QOLIXANE trial of the Platform for Outcome, Quality of Life and Translational Research on Pancreatic Cancer registry
od: Al-Batran, Salah-Eddin, i dr.
Izdano: (2021)